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Abstract
Background: Ca2+ is a ubiquitous messenger that has been shown to be responsible for controlling numerous cellular 
processes including cell growth and cell death. Whereas the involvement of IP3-induced Ca2+ signalling (IICS) in the 
physiological activity of numerous cell types is well documented, the role of IICS in cancer cells is still largely unknown. 
Our purpose was to characterize the role of IICS in the control of growth of the estrogen-dependent human breast 
cancer epithelial cell line MCF-7 and its potential regulation by 17β-estradiol (E2).
Results: Our results show that the IP3 receptor (IP3R) inhibitors caffeine, 2-APB and xestospongin C (XeC) inhibited the 
growth of MCF-7 stimulated by 5% foetal calf serum or 10 nM E2. Furthermore, Ca2+ imaging experiments showed that 
serum and E2 were able to trigger, in a Ca2+-free medium, an elevation of internal Ca2+ in a 2-APB and XeC-sensitive 
manner. Moreover, the phospholipase C (PLC) inhibitor U-73122 was able to prevent intracellular Ca2+ elevation in 
response to serum, whereas the inactive analogue U-73343 was ineffective. Western-blotting experiments revealed 
that the 3 types of IP3Rs are expressed in MCF-7 cells and that a 48 hours treatment with 10 nM E2 elevated IP3R3 
protein expression level in an ICI-182,780 (a specific estrogen receptor antagonist)-dependent manner. Furthermore, 
IP3R3 silencing by the use of specific small interfering RNA was responsible for a drastic modification of the temporal 
feature of IICS, independently of a modification of the sensitivity of the Ca2+ release process and acted to counteract 
the proliferative effect of 10 nM E2.
Conclusions: Altogether, our results are in favour of a role of IICS in MCF-7 cell growth, and we hypothesize that the 
regulation of IP3R3 expression by E2 is involved in this effect.
Background
Ca2+ is a ubiquitous messenger that has been shown to be
responsible for controlling numerous cellular processes
including muscle contraction, exocytosis, gene expres-
sion, cell growth and cell death [1-3]. Numerous studies
have shown that Ca2+ is involved in the control of cellular
growth through its interaction with a plethora of intracel-
lular proteins and cellular transduction pathways. The
Ca2+-dependent processes are often involved in highly
important cellular responses that are strikingly exempli-
f i e d  b y  t h e i r  r o l e  i n  l i f e - a n d - d e a t h  d e c i s i o n s .  C o n s e -
quently, Ca2+ needs to be used in an appropriate manner
to determine cell fate; if this balancing act is compro-
mised, pathology may ensue [4]. In the case of malignant
cells, the importance of Ca2+ homeostasis has been dem-
onstrated by studies showing that some highly phospho-
rylated inositol phosphates [5] and antagonists of the
phosphoinositide pathway [6] or Ca2+ influx [7] arrest the
growth of a variety of tumour cells in culture [8]. Further-
more, it has been shown that Ca2+ plays a central role in
vitamin D-induced cell death in cancerous cells [9-11].
Free intracellular Ca2+ is provided by two main sources: i)
extracellular, through a variety of Ca2+ entry channels, ii)
intracellular, from the endoplasmic reticulum (ER),
mainly through two types of intracellular Ca2+ channels
[i.e. inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) and
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ryanodine receptor]. IP3R protein subtypes (namely
IP3R1, IP3R2 and IP3R3) are encoded by three different
genes in mammals but share high similarity in their pri-
mary sequences and are expressed to varying degrees in
various cell types [12]. Even though they share common
properties, it has been shown, however, that they are
responsible for different types of Ca2+  signals when
expressed alone [13,14]. Temporal characteristics, that is
amplitude, frequency and duration, of the Ca2+ signal
determine its intracellular function [15]. For example, it
has been shown that the encoding of several genes is
dependent on the oscillatory or transitory pattern of the
Ca2+ signal [16,17].
The steroid hormone 17β-estradiol (E2) is a key growth
regulator involved in normal breast development where it
stimulates growth of the ductal system. However, clinical
and experimental data have clearly established that expo-
sure to estrogens is the leading cause of sporadic female
breast cancer [18]. The predominant biological effects of
E2 have traditionally been considered to be based on its
interaction with intracellular estrogen receptors [19].
These act via the regulation of transcriptional processes,
involving nuclear translocation, binding to specific estro-
gen responsive elements and ultimately regulate gene
expression [20-23]. Furthermore, E2 has also been shown
to be involved in cellular responses that do not require
the stimulation of estrogen receptors (i.e. alternative or
non-genomic pathway) [24,25]. Whereas the involvement
of IP3-induced Ca2+ signalling (IICS) in the physiological
activity of numerous cell types is well documented, the
role of IICS in cancer cells is still largely unknown. In the
case of breast cancer cells, only a few studies have
described the Ca2+ release mechanisms [26] and their
potential modulation by E2 and anti-estrogens [27-30].
In this study, we investigate the potential involvement
of E2 in regulating IICS in the estrogen-dependent MCF-
7 cell line. We show that the expression level of IP3R3 is
controlled by E2 in an estrogen receptor-dependent man-
ner and that the growth of MCF-7 cells induced by E2 is
sensitive to pharmacological inhibitors of IP3Rs. Further-
more, IP3R3 gene silencing using specific siRNA dimin-
ishes E2-induced cell growth and changed the temporal
feature of ATP-induced intracellular Ca2+  signals. We
conclude that IICS is involved in E2-induced MCF-7 cell
growth and that the regulation of IP3R3 expression could
explain this effect.
Results
Serum and E2 trigger Ca2+ release from IP3-sensitive stores
As for many other cell types, the growth of MCF-7 cells is
dependent on internal Ca2+ and these cells are able to
elicit intracellular Ca2+ signals in response of multiple
ligands [31]. When Fura-2-loaded MCF-7 cells were per-
fused in a Ca2+-free medium, serum was able to trigger
Ca2+ release (Figure 1Aa) from IP3-sensitive Ca2+ pools
since the internal Ca2+ elevation was inhibited by 58.6 ±
15.3% (n = 56; P < 0.05) by the known IP3R antagonist 2-
APB (75 μM; Figure 1Ab) [32]. In addition, the IP3R
inhibitor XeC (25 μM) similarly inhibited serum-trig-
gered IICS by 64.7 ± 11.7% (Figure 1Ac; n = 49; P < 0.05).
To further assess the role of the IP3R in this process, we
also used the phospholipase C inhibitor U-73122 (20
μM). The latter completely suppressed the serum-
induced intracellular Ca2+ release (Figure 1Ad) whereas
the inactive analogue U-73343 (20 μM) was ineffective
(Figure 1Ad, inset). Finally, we also tested whether E2 was
able to induce intracellular Ca2+ release from IP3-sensitive
stores. Indeed, in the absence of extracellular Ca2+, E2 (10
nM) evoked Ca2+ signals (Figure 1Ba) that were inhibited
for 87.3 ± 10.2% (n = 52; P < 0.05) by 25 μM XeC (Figure
1Bb).
Pharmacological inhibitors of IP3-induced Ca2+ signalling 
inhibited MCF-7 cell growth
In order to verify the possible involvement of IICS in
MCF-7 cell growth, pharmacological inhibitors of IP3R
(i.e. caffeine, 2-APB and XeC) were tested on 5-FCS- and
E2-induced cell growth. As could be expected, cell count-
ing using the trypan-blue exclusion method showed that
5-FCS was able to increase MCF-7 cell growth compared
to a starvation culture medium (Figure 2A). Interestingly,
both caffeine (500 μM) and 2-APB (75 μM) significantly
inhibited cell growth in 5-FCS by 23.0 ± 6.2% (P < 0.05; n
= 18) and 76.2 ± 5.4% (P < 0.001; n = 18), respectively. In
all experiments, the total number of dead cells did not
exceed 5%, thus the increase in cell number could be
attributed to an increase of cell proliferation. Addition of
E2 in the culture medium similarly stimulated cell growth
(Figure 2B). We tested the effect of caffeine on E2-
induced growth. In this latter case, MCF-7 cells were
seeded in 0-FCS for a 24 h period in order to eliminate all
proliferative agents and were then stimulated with E2 for
48 h in the absence or the presence of caffeine (500 μM).
Figure 2B shows that caffeine was able to inhibit by 66.7 ±
3.1% the growth induced by 10 nM E2 (P < 0.01; n = 18).
The cell growth in the presence of caffeine alone was not
statistically different from that in 0-FCS (90.4 ± 5.5%, n =
18 vs 100.0 ± 6.8%, n = 18; P > 0.05). The effect of 2-APB
could not be adequately tested as it triggered even under
control conditions a significant elevation in cell death
(>55%). Furthermore, as caffeine and 2-APB have been
described as non-specific IP3R antagonists, we performed
experiments using XeC, another IP3R inhibitor, in orderSzatkowski et al. Molecular Cancer 2010, 9:156
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Figure 1 Serum triggers an intracellular Ca2+ signal. (A) The perfusion of a Ca2+-free recording solution containing 5% of serum on Fura-2-loaded 
MCF-7 cells elicited a strong intracellular Ca2+ signal (a). This signal was due to release from IP3-sensitive Ca2+ stores as it was sensitive to previous ap-
plication of 2-APB (75 μM, b) or XeC (25 μM, c). Furthermore, U-73122 (20 μM) prevented the effect of serum on intracellular Ca2+ release (d) whereas 
the inactive analogue U-73343 (20 μM) was ineffective (d, inset). (B) E2 (10 nM) triggered intracellular Ca2+ elevations in MCF-7 cells perfused with a 
Ca2+-free medium (a); these Ca2+ elevations were inhibited by XeC (25 μM, b). In each panel, the results show the typical traces of 27 to 35 cells, always 
represented at the same scale; each time, also the mean signal is represented (thick black line).
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to increase the weight of evidence in support of a role for
IICS in stimulating cell proliferation. A concentration of
10 μM XeC was chosen in order to limit potential side
effects of the compound during a long-term treatment;
this concentration was verified to be sufficient to inhibit
E2-induced Ca2+  release (data not shown). Figure 2C
shows that XeC (10 μM) inhibited by 69.3 ± 7.1% (P <
0.05, n = 9) and by 71.0 ± 6.5% (P < 0.001, n = 9) the pro-
liferation induced by 10 nM E2 and 5-FCS, respectively.
Figure 2D demonstrates the kinetics and the reversibil-
ity of the inhibitory effect of caffeine on E2-induced cell
growth. Addition of caffeine (500 μM) at the beginning of
the experiment or at intermediate time (0 h and 36 h, Fig-
ure 2Da and 2b, respectively) reduced the increase of cell
viability induced by E2. The inhibitory effect of caffeine
on the E2-induced cell growth is 46.7 ± 8.3% (P < 0.001; n
= 27) at 36 h and 47.9 ± 8.4% (P < 0.001; n = 27) at 72 h
(Figure 2Da). In the same way, the inhibition is 36.5 ±
Figure 2 Pharmacological inhibitors of IP3Rs inhibited 5-FCS- and E2-induced MCF-7 cell growth. (A) The growth of MCF-7 cells induced by a 
48 h treatment with 5-FCS was sensitive to pharmacological inhibitors of IP3R. Left bar graph shows the cell number obtained in 0-FCS and serves as 
a control experiment in order to estimate the proliferative effect of 5-FCS. Caffeine (500 μM) and 2-APB (75 μM) were both able to inhibit significantly 
5-FCS-stimulated cell growth (P < 0.05 and P < 0.001, respectively). Values are the mean ± S.E.M. of 6 independent experiments. (B) Pharmacological 
inhibition of IP3R was responsible for the inhibition of E2-induced cell growth. Whereas caffeine (500 μM) was ineffective alone in control conditions, 
it inhibited the stimulation of cell growth by E2 (10 nM, P < 0.01). Values are the mean ± S.E.M. of 3 independent experiments. (C) XeC (10 μM) inhibited 
both 5-FCS and E2-induced MCF-7 cell growth. Values are the mean ± S.E.M. of 4 independent experiments. (D) Kinetics and reversibility of the inhibi-
tion by caffeine of E2-induced MCF-7 cell viability. Cells were starved for a 24 h period and were then stimulated by 10 nM E2. Caffeine (500 μM) was 
either added (+caf) at the beginning of the experiment (a), or after 36 h (b). In both cases, caffeine inhibited the E2-induced increase in cell viability (P 
< 0.001). The effect of caffeine was reversible since washout (-caf) of this compound after 36 h permitted to significantly restore the proliferative effect 
of E2 at 72 h (c). Arrows indicate the time of application (downward) or washout (upward) of caffeine. Values are the mean ± S.E.M. of 3 independent 
experiments.
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6.7% (P < 0.001; n = 27) at 72 h when caffeine was added
at the intermediate time (Figure 2Db). On the contrary,
wash-out of caffeine at the intermediate time point signif-
icantly restored the proliferative effect of E2; the cell
growth was in this case indeed 31.3 ± 4.5% (P < 0.001; n =
27) higher compared to the condition in which caffeine
was still present in the culture medium (Figure 2Dc).
Expression of IP3Rs isoforms and their regulation by E2
Considering these results showing the implication of IICS
in MCF-7 cell growth, we carried out western-blotting
experiments on MCF-7 microsomes in order to charac-
terize the types of IP3Rs expressed in these cells and the
potential effect of E2 on their expression level. Figure 3
shows that the 3 types of IP3Rs are expressed. Whereas
the expression level of IP3R1 and IP3R2 remained
unchanged following a 48 h treatment with 10 nM E2
(Figure 3Aa, left and middle panel, respectively), E2 was
able to elevate the expression level of IP3R3 (Figure 3Aa,
right panel). Compared to control conditions, the expres-
sion level was 95.1 ± 14 (P > 0.05, n = 7) for IP3R1, 107.5 ±
12 (P > 0.05, n = 7) for IP3R2 and 140.2 ± 11.3% (P < 0.05;
n = 8) for IP3R3 (Figure 3Ba). Furthermore, this latter
effect was counteracted by the specific antagonist of the
estrogen receptor, ICI-182,780 (1 μM; Figure 3Ab and
Figure 3 Expression of IP3Rs isoforms and their regulation by E2. (A) MCF-7 cells express the three IP3R isoforms. (a) Western blotting allowed the 
specific detection in MCF-7 microsomes (50 μg proteins/lane) of IP3R1, IP3R2 and IP3R3. Representative blots for 7 to 8 independent experiments are 
shown. Whereas E2 had no effect on the expression level of IP3R1 (left panel) and IP3R2 (middle panel), E2 increased the expression of IP3R3 (right panel, 
P < 0.05). This effect of E2 involves an estrogen receptor-dependent intracellular pathway since it was antagonized by the specific anti-estrogen ICI-
182,780 (1 μM, b). (B) Statistical analysis of the effect of E2 on the expression level of the 3 types of IP3Rs (a) and of the inhibitory effect of ICI-182,780 
on E2-induced stimulation of IP3R3 expression (b). In the presence or absence of ICI-182,780, the expression level of IP3R3 is not significantly different 
(113.4 ± 21.9 vs. 100.0 ± 18.2% in control conditions, n = 6).
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3Bb), a compound which is known to inhibit E2-induced
MCF-7 proliferation [[33] and data not shown].
Silencing of IP3R3 by RNA interference limits the 
proliferative effect of E2
In order to further investigate the involvement of IP3R3 in
E2-induced MCF-7 cell growth, the expression of IP3R3 in
MCF-7 cells was silenced by the use of RNA interference.
Figures 4A and 4B depict the efficiency of gene silencing
at respectively the mRNA and the protein level following
transfection of MCF-7 cells with a siRNA directed against
IP3R3 (siR3) or a control siRNA (siC). At 24, 48 and 72 h
post-transfection, siR3 reduced the IP3R3 mRNA by 68.7
± 7.4% (n = 3, P < 0.01), 69.8 ± 6.3% (n = 3, P < 0.01) and
66.2 ± 5.7% (n = 3, P < 0.01), respectively. Also at the pro-
tein level, siR3 induced a similar decrease in IP3R3
expression (Figure 4Bb). The expression of the IP3R3 was
diminished by 70.8 ± 9% (n = 3, P < 0.01), 88.6 ± 6.3% (n =
3, P < 0.001) and 75.4 ± 10.8% (n = 3, P < 0.01) at 24, 48
and 72 h respectively (Figure 4Bb). Treatment with siR3
had no effect on the expression levels of the other IP3R
isoforms and no adaptation phenomenon occurred.
Quantitative PCR experiments show that the level of
IP3R1 and IP3R2 mRNA was not significantly changed
(122.5 ± 18.3%; 95.9 ± 7.2%; 98.8 ± 21.1 for IP3R1 and
120.6 ± 11.9%; 105.0 ± 4.8%; 105.4 ± 16.7% for IP3R2 at 24,
48 and 72 h respectively, n = 3; Figure 4Ca). These latter
results were confirmed by western-blotting experiments
(Figure 4Cb). Compared to control, the level of IP3R1 and
IP3R2 proteins was 105.0 ± 11.9%; 96.1 ± 14.2%; 108.2 ±
11.2 for IP3R1 and 108.9 ± 5.2%; 102.3 ± 9.8%; 104.4 ±
10.5% for IP3R2 at 24, 48 and 72 h, n = 4; respectively).
Subsequently , we tested the effect of siR3 on the E 2-
induced MCF-7 cell growth. Cells were transfected with
either siC or siR3 and seeded in 5-FCS for 18 hours. After
that, cells were starved for 6 h before being stimulated
with 10 nM E2 for 48 hours. Whereas siR3 did not signifi-
cantly modify the growth of MCF-7 cells in the absence of
E2 (90.7 ± 9.1% of control; n = 27; P > 0.05), it appeared
that siR3 was able to inhibit E2-induced increase in cell
number by 63.2 ± 6.7% (n = 27, P < 0.01, Figure 4C). E2
stimulated MCF-7 cell growth by 89.4 ± 18% (n = 27, P <
0.001) in siC-transfected cells and only by 32.9 ± 12.6% (n
= 27; P > 0.05) in siR3-transfected cells. Taken together,
this strongly suggests that the Ca2+ signal resulting from
the activation of IP3R3 is at least partly involved in the
proliferative effect of E2.
IP3R3 silencing changed the temporal characteristics of 
intracellular Ca2+ signalling
We then determined the effect of IP3R3 silencing on the
intracellular Ca2+ signals in response to ATP. ATP delivers
very reproducible, standardized Ca2+ signals that could be
easily analyzed and quantified; furthermore, ATP is also
able to stimulate MCF-7 proliferation [34]. Typical Fura-2
traces obtained after the perfusion of the cells with ATP
(5 μM) in a Ca2+-free medium after 72 hours of transfec-
tion with either siC or siR3 are depicted in Figure 5A.
Decreased IP3R3 levels provoked a drastic change in the
characteristics of the ATP-induced Ca2+ signal. Indeed,
Ca2+ signals changed from a plateau-type of response to a
sinusoidal oscillatory-shaped signal. Statistical analysis
revealed that at 24, 48 and 72 h post-transfection, the
number of oscillating cells in response to ATP was much
higher in siR3-transfected cells compared to siC-trans-
fected cells (Figure 5B). The respective percentages of
oscillating cells at 24, 48 and 72 h in siC-transfected cells
versus siR3-transfected cells are 15.6 ± 4.4% (n = 6) vs
56.1 ± 8.9% (n = 6, P < 0.001); 13.9 ± 2.5% (n = 6) vs 41.1 ±
5.4% (n = 6, P < 0.01) and 15.1 ± 2.5% (n = 6) vs 78.3 ±
3.9% (n = 6, P < 0.001). In order to measure and compare
the elevation of internal Ca2+ concentration in siC- and
siR3-transfected MCF-7 cells, we calculated the "area
under curve" (AUC) for each trace. Figure 5C represents
typical Ca2+ signals measured at 72 h post-transfection in
both conditions after perfusion with 5 μM ATP in a Ca2+-
free medium. Superimposition of both traces clearly sug-
gests that despite the pattern of the Ca2+  signal was
changed, the global amount of Ca2+ released into the cell
remained the same. This latter point was confirmed fol-
lowing statistical analysis. Indeed, the mean AUC values
for Ca2+ signals elicited in siC-transfected cells versus
siR3-transfected cells were not statistically different
(Table 1) whatever the time post-transfection tested (24,
48 and 72 h).
IP3R3 silencing does not modify the sensitivity of IICS
To further uncover how calcium signalling is affected by
down regulation of IP3R3 expression, the sensitivity of the
calcium release process and the magnitude of the calcium
release at maximal agonist concentration were investi-
gated (Figure 6). We have therefore performed experi-
ments using different ATP concentrations (ranging from
50 nM to 100 μM) in control (siC-transfected, Figure
6Aa) and in siR3-transfected MCF-7 cells (Figure 6Ab),
72 h after the transfection. Figure 6A clearly demon-
strates that the sensitivity of the Ca2+ release process
remains virtually unchanged since the threshold for ATP
(about 100 nM) is the same for both types of cells. Fur-
thermore, the percentage of responding cells is
unchanged in siC vs siR3-transfected cells (Figure 6Ac).
Values are 4.1 ± 0.9% vs 3.8 ± 0.8% (P > 0.05); 78.2 ± 3.1%
vs 81.9 ± 2.8% (P > 0.05) and 94.3 ± 4.2% vs 95.5 ± 3.8% (P
> 0.05) at 0.05, 0.1 and 0.5 μM ATP, respectively. For
higher ATP concentrations (i.e. 5 and 100 μM) all the cells
were responsive. However, the magnitude of the Ca2+ sig-Szatkowski et al. Molecular Cancer 2010, 9:156
http://www.molecular-cancer.com/content/9/1/156
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Figure 4 Silencing of IP3R3 by RNA interference limits the proliferative effect of E2. (A) Validation of the efficiency of the siRNAs used at the 
mRNA level (a, representative illustrations for 3 independent experiments). The IP3R3 mRNA level was lowered by about 70% (see text for details) at 
24, 48 and 72 h post-transfection. (B) siR3 was responsible for a rapid and long-lasting diminution of the expression of IP3R3 at the protein level (a). 
Compared to control conditions, siR3 diminished the expression of IP3R3 at 24, 48 and 72 h (b). (C) Following IP3R3 silencing, the levels of IP3R1 and 
IP3R2 mRNA (a) and protein (b) were not significantly changed at 24, 48 and 72 h post-transfection. Representative blots for 3 to 4 independent west-
ern blotting experiments are shown. (D) MCF-7 cells were transfected with siC or siR3 and seeded for 18 h in 5-FCS and then starved for 6 h in 0-FCS. 
Cells were subsequently cultured in 0-FCS in the absence (-E2) of the presence (+E2) of E2 (10 nM) for 48 h. MCF-7 cell number was measured at 72 h 
post-transfection using the trypan-blue exclusion method. E2-induced increase in cell number was strongly diminished in siR3-transfected MCF-7 cells 
compared to siC-transfected cells (P < 0.01).
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nal (measurement of the AUC) is significantly diminished
by 18.4 ± 5.7% (n = 76, P < 0.01; Figure 6B) at maximal
ATP concentration. Indeed, the mean AUC (arbitrary
unit) is 21.4 ± 4.4 vs 22.3 ± 4.9 at 100 nM ATP; 54.2 ± 11.7
vs 49.6 ± 12.2 at 500 nM ATP; 132.8 ± 15.2 vs 138.1 ± 13.5
at 5 μM ATP; and 184.4 ± 8.5 vs 150.5 ± 6.5 at 100 μM
ATP, for siC- versus siR3-transfected cells, respectively.
Finally, our results clearly demonstrate that the main dif-
ference between the cell types is the dramatic increase in
the percentage of cells demonstrating an oscillating Ca2+
signal pattern at all submaximal ATP concentrations after
IP3R3 down regulation (Figure 6C): the mean percentage
of cells demonstrating an oscillating pattern increased
from 5.1 ± 0.9% to 33.3 ± 2.7% at 100 nM ATP; from 16.1
± 1.9% to 41.4 ± 3.5% at 500 nM ATP and from 15.2 ±
2.5% to 78.3 ± 3.9% at 5 μM ATP, at each concentration in
siC and siR3-transfected cells, respectively.
Discussion
We showed in this study that MCF-7 cells express the 3
IP3R isoforms and that intracellular Ca2+ release through
these channels plays a role in the control of the growth of
these cells. Indeed, using both pharmacological inhibitors
and specific small inhibitory RNAs, we showed that IICS
is involved in the increase in cell growth in response to
addition of serum or E2. Our results are in agreement
with previous studies showing that intracellular Ca2+ ele-
vation following ER emptying is crucial in order to ensure
the activation by E2 of various protein kinases involved in
cell cycle, such as mitogen-activated protein kinase, and
to trigger MCF-7 cell proliferation [35]. In the same way,
numerous studies have shown that IICS was responsible
for stimulating the proliferation of various cell types [2]
s u c h  a s  c e r e b r a l  a r t e r y  s m o o t h  m u s c l e  c e l l s  [ 3 6 ]  a n d
mouse cholangiocytes [37]. It has also been shown in gas-
tric cancer cells that 2-APB inhibits cell proliferation and
that IP3R3 belongs to genes that are over expressed in the
case of peritoneal dissemination [38]. In the case of breast
cancer, a few studies have shown that IP3R could be the
target of a variety of proteins such as Bcl-2 and cyclins
that might affect cell viability by respectively suppressing
apoptosis [29,30] and probably stimulating proliferation
[39]. Interestingly, this study demonstrates that IP3R3
expression is up regulated by E2. Moreover, this regula-
tion occurs in an estrogen receptor-dependent manner
since it was sensitive to ICI-182,780, a compound known
to inhibit E2-induced MCF-7 cell proliferation [33]. As
the proliferative effect of E2 involves IICS, we hypothe-
sized that this could be, at least in part, due to the
increased IP3R3 expression. This result is strengthened
by the numerous studies showing a potential regulation
of the expression level of IP3Rs by many factors, such as
retinoic acid, TGF-β or phorbol esters [see 40 for review].
In particular, expression of IP3R isoforms has been shown
to be controlled by steroids such as progesterone and E2
[41-43] or glucocorticoids [44]. Furthermore, an
increased expression of IP3Rs has been described in pro-
liferating arterial smooth muscle cell [45]. Other studies
have already shown that the relative expression of the dif-
ferent IP3R isoforms is responsible for generating various
Ca2+ signals in term of duration, amplitude and shape (i.e.
transient or oscillatory) [13]. For example, it has been
shown that IP3R3 functions as an anti Ca2+-oscillatory
unit in DT-40 cells [13] and in HeLa and COS-7 cells [14].
In full agreement with this, we demonstrated, on the
basis of the results obtained using siRNA, that changing
the IP3R3 levels in MCF-7 cells drastically changed the
characteristics of the Ca2+  signals. Importantly, no
Table 1: IP3R3 silencing does not modify the AUC of intracellular Ca2+ signals
Time post-transfection siRNA Mean AUC ± SD (n) P value
24 h siC 16.8 ± 6.5 (77) 0.392
siR3 17.1 ± 6.5 (88)
48 h siC 18.7 ± 4.5 (79) 0.112
siR3 19.5 ± 3.9 (83)
72 h siC 16.6 ± 5.9 (89) 0.125
siR3 17.5 ± 4.2 (90)
Statistical analysis of the effect of IP3R3 gene silencing on the AUC of Ca2+ signals elicited by ATP (5 μM) in Ca2+-free medium. At any time after 
the transfection, the global amount of Ca2+ released as assessed from the AUC appears unchanged between the cells treated with siC or siR3.Szatkowski et al. Molecular Cancer 2010, 9:156
http://www.molecular-cancer.com/content/9/1/156
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changes occurred in the sensitivity of the Ca2+ signals to
ATP after down-regulation of IP3R3, which is probably
due to the expression of IP3R1 and IP3R2 which have a
higher affinity for IP3 [13]. At maximal ATP stimulation, a
small decrease in total Ca2+ release was observed, but the
largest difference was the profound increase (3- to 7-fold,
depending on the ATP concentration used) in the num-
ber of cells displaying a pattern of sinusoidal Ca2+ oscilla-
tions instead of a plateau phase. This fully supports the
hypothesis that E2 partly controls MCF-7 cell growth by
encoding specific Ca2+ signals through the IP3R3. A rela-
tion between Ca2+ oscillation frequency and transcription
factors has already been shown [16,17]. It can therefore
be hypothesized that the decrease in cell proliferation fol-
lowing IP3R3 silencing could be related to the modifica-
tion of the temporal feature of the Ca2+ signal.
Our results obtained following IP3R3 silencing show
that basal MCF-7 proliferation in serum-deprived
medium is not affected. This is due to the fact that in
those conditions there is no factor present that can trig-
ger internal Ca2+ release. We have previously observed
[24] a similar phenomenon in MCF-7 cells where iberio-
toxin, an inhibitor of the voltage- and Ca2+-dependent K+
channel BK, could impair the proliferation induced by E2
Figure 5 IP3R3 silencing changed the characteristics of ATP-in-
duced Ca2+ signalling in MCF-7 cells. (A) Typical ATP-induced Ca2+ 
signals in MCF-7 cells 72 h after their transfection with siC (a) or siR3 (b). 
ATP (5 μM) was perfused in a Ca2+-free recording solution in order to 
avoid Ca2+ entry. The Ca2+ response changed from a plateau-type pat-
tern to a characteristic oscillatory pattern in siR3-transfected cells. Rep-
resentative for 6 independent experiments. (B) Statistical analysis of 
the effect of IP3R3 silencing at 24, 48 and 72 h post-transfection on the 
percentage of oscillating cells in response to 5 μM ATP in a Ca2+-free 
recording solution. IP3R3 gene silencing resulted, at any time, in a 
strong augmentation of the percentage of cells that respond to ATP by 
an oscillatory Ca2+ signal. (C) Typical ATP-induced Ca2+ signals record-
ed in a Ca2+-free medium 72 h after transfection with siC (a) or siR3 (b). 
Ca2+ signals presented in a (full line) and b (dotted line) were superim-
posed in order to clearly show the modification of the pattern of the 
Ca2+ response (c).
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Figure 6 IP3R3 silencing does not modify the sensitivity of the 
Ca2+ release process. (A) Typical Ca2+ signals induced by ATP (50 nM - 
100 μM) in Fura-2-loaded MCF-7 cells 72 h after their transfection with 
siC (a) or siR3 (b). ATP triggered intracellular Ca2+ signals with a concen-
tration threshold of about 100 nM in both cell batches but IP3R3 silenc-
ing was responsible for a change in the shape of the signal. The 
percentage of responding cells in siC- and siR3-transfected cells is un-
changed whatever the concentration of ATP used (c). Results are rep-
resentative of 8 independent experiments. (B) The magnitude of the 
signal is compared at various ATP concentrations (100 nM - 100 μM) 
and at the maximal concentration of ATP used, the magnitude of the 
signal is significantly decreased by about 20% (P < 0.01). (C) The num-
ber of oscillating cells was investigated at ATP concentrations ranging 
from 100 nM to 5 μM, and at each concentration the percentage of os-
cillating cells was largely greater in siR3-transfected cells (P < 0.01 or 
0.001).
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but not in basal conditions (0 FCS). Indeed, in the latter
condition, basal Ca2+  activity is probably too low to
ensure the activation of the BK channels while after
induction with E2, the internal Ca2+ level is sufficiently
elevated to activate these channels and therefore to
uncover the sensitivity to iberiotoxin.
Interestingly, our study demonstrates a link between
IP3R3 expression and cellular proliferation, though IP3R3
has also been previously implicated in cell death [46]. It is
thought that IP3Rs and IICS can convey and/or enhance
cell death signals by allowing for an efficient Ca2+ shut-
tling between ER and mitochondria leading to mitochon-
drial Ca2+ overload (see [47] for review). This efficient
shuttling is only possible when the IP3R is closely aposi-
tioned to the mitochondria through physical interaction
e.g. with the mitochondrial voltage-dependent anion
channel. Several proteins can participate in this interac-
tion, including glucose-regulated protein 75 and the
sigma receptor Sig-1R [47]. This increased apoptosis does
not seem to occur in the MCF-7 cells, what may be due
either to the nearly complete absence of Sig-1R in those
cells [48], or to additional regulation limiting the extent of
Ca2+  release and Ca2+ transfer into mitochondrion by
anti-apoptotic proteins as protein kinase B [49] or Bcl-2
[50]. Interestingly, the expression of the latter protein is
up regulated by E2 in MCF-7 cells [51].
These various mechanisms may explain why, even
though IP3R3 expression is increased in response to E2,
apoptosis is not stimulated. The increased proliferation
can therefore be due to each or both of the following ele-
ments, (1) a stimulation of cell metabolism and ATP pro-
duction by a low to intermediate flux of Ca2+ to the
mitochondria, large enough to stimulate the Ca2+-sensi-
tive mitochondrial dehydrogenases but not to cause det-
rimental effects and (2) Ca2+  signals with a temporal
pattern able to activate more efficiently transcription fac-
tors acting on the expression of genes involved in prolif-
eration.
In conclusion, our observations indicate that the
growth of MCF-7 human breast cancer cells induced by
E2  is sensitive to pharmacological inhibitors of IP3Rs.
Moreover, E2 treatment induced an upregulation of IP3R3
in an estrogen receptor-dependent manner while IP3R3
gene silencing affected both intracellular Ca2+ signalling
and cellular proliferation. Taken together, these results
are suggestive in MCF-7 cells for a regulation of cell
g r o w t h  b y  s p e c i f i c  C a 2+  signals, but further work is
needed to elucidate the precise mechanism(s) involved.
Materials and Methods
Cell culture
The MCF-7 cell line was purchased from the American
Type Culture Collection (ATCC®  HTB-22™, LGC Pro-
mochem) and cells were used for a maximum of 10 pas-
sages after receipt or resuscitation. Cells were grown in
an atmosphere saturated with humidity at 37°C and 5%
CO2 in Eagle's Minimal Essential Medium supplemented
with 2 mM L-glutamine, 0.06% HEPES Buffer and a mix-
ture of penicillin (50 UI/ml)/streptomycin (50 μg/ml). In
addition, the culture medium was either supplemented
with 5% FCS (5-FCS) or not supplemented with FCS (0-
FCS) and was renewed every two days.
Cell viability
For cell growth assays, 75,000 MCF-7 cells were seeded in
Petri dishes (diameter 60 mm) in 5-FCS. After 48 h, cells
were incubated in a phenol-red-free 0-FCS for a 24 h
starvation period. Cells were then washed and incubated
with E2 (10 nM) or 5-FCS, alone or in association with
caffeine (500 μM) or 2-APB (75 μM). After 2 days of
treatment, the cell number was determined by trypan
blue exclusion method. The counts were replicated six
times and the experiments were repeated at least three
t i m e s.  A l t e r n a t i v e l y ,  c e l l  vi a b i l i t y  was  m eas u r ed  b y  t h e
use of the 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltet-
razolium bromide reduction assay (MTT-assay) [52]. In
brief, MCF-7 cells were plated in 6-well plates at 5.104
cells per well and allowed to grow for 48 h. Cells under-
went a 24 h starvation in 0-FCS and were then stimulated
with 10 nM E2 in the presence or the absence of caffeine
(500 μM) for 36 h and 72 h. On the day of assay, treatment
medium was replaced with medium containing 0.5 mg/
ml of MTT and incubated for 1 h at 37°C. Medium was
then aspirated off and 800 μl of DMSO was added to sol-
ubilise crystals. The optical density of each sample was
read on a microplate reader (MRX II; Revelation software
4.22) at 570 nm against a blank prepared from cell-free
wells.
Ca2+ imaging
MCF-7 cells were cultured at 5.104 cells per dish on glass
cover slips and cells were loaded for 1 h with Fura-2/AM
(3 μM in saline solution) at 37°C in a CO2 incubator and
subsequently washed three times with the dye-free
recording solution. The cover slip was then transferred
into a perfusion chamber of a Zeiss inverted microscope
equipped for fluorescence. Fluorescence was excited at
340 and 380 nm alternately, using a monochromator
(Polychrome IV; TILL Photonics), and captured by a Cool
SNAP HQ camera (Princeton Instruments) after filtra-
tion through a long-pass filter (510 nm). Background flu-
orescence was determined at 340 and 380 nm from an
area of the cover slip free of cells. These values were rou-
tinely subtracted. Metafluor software (v.6.2; Universal
Imaging, West Chester, PA) was used for acquisition and
analysis. All recordings were carried out at room temper-
ature (RT; 20-22°C). The cells were continuously perfusedSzatkowski et al. Molecular Cancer 2010, 9:156
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with the saline solution, and chemicals were added via the
perfusion system. The flow rate of the whole-chamber
perfusion system was set at 10 ml/min, and the chamber
volume was 1 ml. Recording solution had the following
composition (in mM): NaCl 145, KCl 5, CaCl2 2, MgCl2 1,
and Hepes 10 at pH 7.4 (NaOH). In experiments where
Ca2+-free solution was used, Ca2+ was omitted and EGTA
(1 mM) was added to the solution. The "Area Under
Curve" (AUC) was calculated using OriginPro v.8 and
permitted to measure the global amount of Ca2+ released
into the cells following stimulation.
Western Blotting
Cells were washed twice with phosphate-buffered saline
(PBS) and lysed by addition of RIPA buffer (200 μl/60 mm
dish) containing protease inhibitor cocktail (Sigma
P8340, 8 μl/ml). After 30-45 min incubation on ice, the
cell lysates were scraped off the Petri dish and transferred
to 1.5 ml tubes. The extracts were then centrifuged at
10,000 × g for 10 min at 4°C in a table-top centrifuge and
the supernatants were saved for analysis. For the determi-
nation of the effect of E2 on the expression level of the
various IP3R isoforms, microsomal preparations from
MCF-7 cells were performed according to an earlier pub-
lished procedure [53]. Protein concentration was deter-
mined using the BCA method and the amount of lysates
or of microsomes corresponding to 50 μg of protein was
denatured with SDS sample buffer and separated on 4-
15% precast SDS-polyacrylamide gels (Bio-Rad). Proteins
were then transferred overnight at 4°C to Immobilon-P
PVDF membranes (0.6 mA/cm² constant current; Bio-
Rad) in Tris-glycine buffer without methanol. Transfer
membranes were incubated for 1 h at RT in Tris-buffered
saline containing 0.1% Tween 20 (TBS-T) and 5% dry
milk and then incubated overnight at 4°C in primary anti-
bodies: goat anti-β-actin (1/2,000; Santa Cruz) as loading
control, rabbit anti-IP3R1 (Rbt03, 1/1,000) [54]; rabbit
anti-IP3R2 (CT2, 1/30) [55]; purified mouse anti-IP3R3
(610313; 1/2,000; BD Bioscience). Following primary
antibody probing, the membranes were washed three
times with TBS-T and incubated for 1 h at RT with the
respective secondary horseradish-peroxidase-conjugated
antibodies (Santa Cruz): anti-mouse (1/5,000) was used
for the detection of IP3R3, anti-rabbit (1/5,000) for IP3R1
and IP3R2 and anti-goat (1/5,000) was used for the detec-
t i o n  o f  β - a c t i n .  P r o t e i n s  w e r e  v i s u a l i z e d  u s i n g  t h e
enhanced chemiluminescence system (Amersham) on a
Chemidoc Apparatus and quantification was realized
using Quantity One software.
Total RNA isolation, reverse transcription of RNA and PCR 
experiments
Total RNA from MCF-7 cells was extracted by the Trizol-
phenol-chloroform (Sigma Aldrich) procedure, including
DNAse I treatment (0.2 U/μl, 30 min at 37°C, Promega).
Total RNA was then reverse-transcribed into cDNA
using oligodT primers and MultiScribe™ reverse tran-
scriptase (Applied Biosystems). PCR experiments were
carried out on an iCycler thermal cycler (Bio-rad) using
Taq DNA polymerase (Invitrogen). PCR products were
analysed by electrophoresis on 1.5% agarose gel and visu-
alized by ethidium bromide staining. Finally, PCR prod-
ucts were quantified using Quantity One software and
expressed as the ratio of IP3Rs on β-actin reference gene.
Cell transfection
MCF-7 cells were collected after trypinization and sub-
mitted to electroporation using a Gene Pulser® apparatus
according to the manufacturer's instructions. Briefly,
2.106 cells were transfected with 2 μg siRNA directed
against the human IP3R 3  m R N A  s e q u e n c e  ( O N - T A R -
GETplus, Dharmacon) or control siRNA (siGENOME
non-targeting siRNA; Dharmacon). After the electropo-
ration (program E-14), 500 μl of prewarmed culture
medium were added and cells were transferred to a 1.5 ml
tube and placed at 37°C for 15 min in a CO2 incubator.
After that, cells were seeded in Petri dishes (diameter 60
mm). 18 h later, cells were treated for 6 h in 0-FCS and
were then stimulated with E2 (10 nM) for 48 h.
Statistical analysis
Results were expressed as mean ± S.E.M. Experiments
were repeated at least three times. The Student's t-test
was used to compare treatment means with control
means. Statistical significance is indicated in the figures
(NS, not significant; * P < 0.05; ** P < 0.01; *** P < 0.001).
Reagents
All the products were from Sigma (France) unless other-
wise stated. Final concentrations were obtained by appro-
priate dilution of stock solutions so that the solvent never
exceeded 1/1,000.
Abbreviations used
IP3: inositol 1,4,5-trisphosphate; IP3R: IP3 receptor; IICS:
IP3-induced Ca2+ signalling; E2: 17β-estradiol; 2-APB: 2-
aminoethoxydiphenyl borate; XeC: xestospongin C; FCS:
foetal calf serum; 5-FCS: culture medium containing 5%
FCS; 0-FCS: serum-deprived culture medium; ER: endo-
plasmic reticulum.
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